Glioblastoma chemotherapy adjunct via potent serotonin receptor-7 inhibition using currently marketed high-affinity antipsychotic medicines.
about
Long-term survival in a patient with glioblastoma on antipsychotic therapy for schizophrenia: a case report and literature reviewPhosphorylated STAT5 directly facilitates parvovirus B19 DNA replication in human erythroid progenitors through interaction with the MCM complexRepurposing antipsychotics as glioblastoma therapeutics: Potentials and challengesPredicting drug-target interactions using probabilistic matrix factorization.Tumor progression: the neuronal input.
P2860
Glioblastoma chemotherapy adjunct via potent serotonin receptor-7 inhibition using currently marketed high-affinity antipsychotic medicines.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Glioblastoma chemotherapy adju ...... inity antipsychotic medicines.
@en
Glioblastoma chemotherapy adju ...... inity antipsychotic medicines.
@nl
type
label
Glioblastoma chemotherapy adju ...... inity antipsychotic medicines.
@en
Glioblastoma chemotherapy adju ...... inity antipsychotic medicines.
@nl
prefLabel
Glioblastoma chemotherapy adju ...... inity antipsychotic medicines.
@en
Glioblastoma chemotherapy adju ...... inity antipsychotic medicines.
@nl
P2860
P1476
Glioblastoma chemotherapy adju ...... inity antipsychotic medicines.
@en
P2093
P2860
P304
P356
10.1111/J.1476-5381.2010.00923.X
P407
P577
2010-10-01T00:00:00Z